These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36768551)

  • 21. Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study.
    Sohan M; Qusar MMAS; Shahriar M; Islam SMA; Bhuiyan MA; Islam MR
    PLoS One; 2023; 18(7):e0288159. PubMed ID: 37399205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined static and dynamic functional connectivity signatures differentiating bipolar depression from major depressive disorder.
    Pang Y; Zhang H; Cui Q; Yang Q; Lu F; Chen H; He Z; Wang Y; Wang J; Chen H
    Aust N Z J Psychiatry; 2020 Aug; 54(8):832-842. PubMed ID: 32456443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCF4 and RBFOX1 as peripheral biomarkers for the differential diagnosis and treatment of major depressive disorder.
    Xu K; Ren Y; Fan L; Zhao S; Feng J; Zhong Q; Tu D; Wu W; Chen J; Xie P
    J Affect Disord; 2024 Jan; 345():252-261. PubMed ID: 37890537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma metabolome analysis of patients with major depressive disorder.
    Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
    Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
    Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
    J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study.
    Islam S; Islam T; Nahar Z; Shahriar M; Islam SMA; Bhuiyan MA; Islam MR
    PLoS One; 2022; 17(11):e0276619. PubMed ID: 36409748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy.
    Emon MPZ; Das R; Nishuty NL; Shalahuddin Qusar MMA; Bhuiyan MA; Islam MR
    BMC Res Notes; 2020 Feb; 13(1):83. PubMed ID: 32085720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
    Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
    J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of nucleotide metabolites and amino acids patterns in patients with eating disorders, with and without symptoms of depression.
    Peplinska-Miaskowska J; Wichowicz H; Smoleński R; Jablonska P; Kaska L
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(3):333-341. PubMed ID: 35076345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles.
    Xie XH; Lai WT; Xu SX; Di Forti M; Zhang JY; Chen MM; Yao LH; Wang P; Hao KK; Rong H
    Brain Behav Immun; 2023 Mar; 109():51-62. PubMed ID: 36587855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder.
    Supti KF; Asaduzzaman M; Suhee FI; Shahriar M; Islam SMA; Bhuiyan MA; Qusar MS; Islam MR
    Clin Pathol; 2023; 16():2632010X231220841. PubMed ID: 38144435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses.
    Lee J; Joo EJ; Lim HJ; Park JM; Lee KY; Park A; Seok A; Lee H; Kang HG
    Psychiatry Investig; 2015 Apr; 12(2):249-59. PubMed ID: 25866527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case-control study.
    Salsabil L; Shahriar M; Islam SMA; Bhuiyan MA; Qusar MS; Islam MR
    J Int Med Res; 2023 Apr; 51(4):3000605231166222. PubMed ID: 37038918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional metabolic heterogeneity in anterior cingulate cortex in major depressive disorder: A multi-voxel
    He J; Wang D; Ban M; Kong L; Xiao Q; Yuan F; Zhu X
    J Affect Disord; 2022 Dec; 318():263-271. PubMed ID: 36087788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics-based discrimination of patients with remitted depression from healthy controls using
    Hung CI; Lin G; Chiang MH; Chiu CY
    Sci Rep; 2021 Aug; 11(1):15608. PubMed ID: 34341439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.